SMYD2 and squamous cell carcinoma: Approximately 60–70% of patients with human papillomavirus (HPV)-unrelated head and neck squamous cell carcinoma (HNSCC), another type of squamous cell carcinoma, have SMYD2 overexpression, and these patients have a worse overall survival rate than those with low SMYD2 expression [76].